Cargando…

Fibrinolysis in a lipid environment: modulation through release of free fatty acids

Background: Thrombolysis is conventionally regarded as dissolution of the fibrin matrix of thrombi by plasmin, but the structure of clots in vivo includes additional constituents (proteins, phospholipids) that modulate their solubilization. Objective: We examined the presence of free fatty acids in...

Descripción completa

Detalles Bibliográficos
Autores principales:	RÁBAI, G, VÁRADI, B, LONGSTAFF, C, SÓTONYI, P, KRISTÓF, V, TIMÁR, F, MACHOVICH, R, KOLEV, K
Formato:	Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2007
Materias:	Fibrinolysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1974781/ https://www.ncbi.nlm.nih.gov/pubmed/17403096 http://dx.doi.org/10.1111/j.1538-7836.2007.02556.x

Ejemplares similares

Hindered dissolution of fibrin formed under mechanical stress
por: Varjú, I, et al.
Publicado: (2011)

Lytic and mechanical stability of clots composed of fibrin and blood vessel wall components
por: Rottenberger, Z, et al.
Publicado: (2013)

Model thrombi formed under flow reveal the role of factor XIII-mediated cross-linking in resistance to fibrinolysis
por: Mutch, N J, et al.
Publicado: (2010)

VhH anti‐thrombomodulin clone 1 inhibits TAFI activation and enhances fibrinolysis in human whole blood under flow
por: van Moorsel, Marc V. A., et al.
Publicado: (2022)

Increased urokinase and consumption of α(2)‐antiplasmin as an explanation for the loss of benefit of tranexamic acid after treatment delay
por: Longstaff, C., et al.
Publicado: (2018)

Leukemia‐associated Rho guanine‐nucleotide exchange factor is not critical for RhoA regulation, yet is important for platelet activation and thrombosis in mice
por: Williams, C. M., et al.
Publicado: (2015)

On the localization of the cleavage site in human alpha‐2‐antiplasmin, involved in the generation of the non‐plasminogen binding form
por: Abdul, Shiraazkhan, et al.
Publicado: (2020)

Contribution of neutrophil elastase to the lysis of obliterative thrombi in the context of their platelet and fibrin content
por: Rábai, Gyöngyi, et al.
Publicado: (2010)

Long-Acting Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Children: Results of a Phase 3 Trial
por: Kenet, Gili, et al.
Publicado: (2016)

Polyphosphate Delays Fibrin Polymerisation and Alters the Mechanical Properties of the Fibrin Network
por: Whyte, Claire S., et al.
Publicado: (2016)

Impact of Fibrinogen Carbamylation on Fibrin Clot Formation and Stability
por: Binder, Veronika, et al.
Publicado: (2017)

Pharmacokinetics of Recombinant Human Soluble Thrombomodulin in Disseminated Intravascular Coagulation Patients with Acute Renal Dysfunction
por: Hayakawa, Mineji, et al.
Publicado: (2017)

Are Cardiovascular Risk Factors also Associated with the Incidence of Atrial Fibrillation?: A Systematic Review and Field Synopsis of 23 Factors in 32 Population-Based Cohorts of 20 Million Participants
por: Allan, Victoria, et al.
Publicado: (2017)

Platelet Turnover Predicts Outcome after Coronary Intervention
por: Freynhofer, Matthias K., et al.
Publicado: (2017)

Switching warfarin patients to a direct oral anticoagulant during the Coronavirus Disease-19 pandemic
por: Patel, Rachna, et al.
Publicado: (2021)

Bleeding related to disturbed fibrinolysis
por: Kolev, Krasimir, et al.
Publicado: (2016)

THE EFFECT OF THE COVID-19 PANDEMIC PROCESS ON TREATMENT COMPLIANCE IN HEMOPHILIA PATIENTS
por: Şahin, Şifa, et al.
Publicado: (2022)

Suppressed catalytic efficiency of plasmin in the presence of long-chain fatty acids
por: Tanka-Salamon, Anna, et al.
Publicado: (2008)

Neutrophil granulocyte-dependent proteolysis enhances platelet adhesion to the arterial wall under high-shear flow
por: WOHNER, N, et al.
Publicado: (2010)

Editorial: Fibrinolysis in Immunity
por: Kolev, Krasimir, et al.
Publicado: (2020)

Study of Coagulopathies in Covid 19 Positive Patients & Their Correlation with Outcome of Disease
por: Khunger, Jitender, et al.
Publicado: (2020)

VWF/ADAMTS13 Ratios Are Potential Markers of Immunothrombotic Complications in Patients with COVID-19: A Cross-Sectional Study
por: Madeeva, Daria V, et al.
Publicado: (2020)

COVID-19 in Relation to Hematological Events (Thrombosis/Bleeding) and Mortality in Inpatient Setting
por: Gadde, Saikrishna, et al.
Publicado: (2020)

Plasma Exchange for COVID-19 Thrombo-Inflammatory Disease
por: Thomas, Mari, et al.
Publicado: (2020)

Venous Thromboembolic Disease in Children Associated with COVID-19
por: Narang, Shalu, et al.
Publicado: (2020)

Coagulation Dysfunction and Hematological Changes in 633 Patients with COVID-19
por: Yang, Mo, et al.
Publicado: (2020)

Frequency of Venous Thromboembolism in 6513 Patients with COVID-19: A Retrospective Study
por: Crowther, Mark, et al.
Publicado: (2020)

Modulation of the von Willebrand factor-dependent platelet adhesion through alternative proteolytic pathways
por: Wohner, Nikolett, et al.
Publicado: (2012)

Ambivalent roles of carboxypeptidase B in the lytic susceptibility of fibrin()
por: Kovács, András, et al.
Publicado: (2014)

The interplay between tissue plasminogen activator domains and fibrin structures in the regulation of fibrinolysis: kinetic and microscopic studies
por: Longstaff, Colin, et al.
Publicado: (2011)

Measuring fibrinolysis: from research to routine diagnostic assays
por: Longstaff, C.
Publicado: (2018)

Implication of Free Fatty Acids in Thrombin Generation and Fibrinolysis in Vascular Inflammation in Zucker Rats and Evolution with Aging
por: Lagrange, Jérémy, et al.
Publicado: (2017)

P1668: SYNERGY OF RED BLOOD CELLS AND TRANEXAMIC ACID IN THE INHIBITION OF FIBRINOLYSIS
por: Raska, A., et al.
Publicado: (2022)

Free Fatty Acids Modulate Thrombin Mediated Fibrin Generation Resulting in Less Stable Clots
por: Tanka-Salamon, Anna, et al.
Publicado: (2016)

Pharmacological Fibrinolysis
por: Fearnley, G. R.
Publicado: (1969)

Rapid Disappearance of Lupus Anticoagulant in Novel Coronavirus 2019 Patients; Is It the Key to Pandora's Box?
por: Kim, Hyunji, et al.
Publicado: (2021)

Hemophilia in Patients 50 Years or Older: Quality of Life, Health Maintenance, Cancer Screening and COVID19
por: Katiyar, Vatsala, et al.
Publicado: (2021)

In Covid-19 Infection, Plasma Extracellular Vesicle Tissue Factor Activity Does Not Correlate with D-Dimer Levels
por: Girard, Thomas J., et al.
Publicado: (2021)

A Case Series of Acquired Factor Inhibitor Following Sars-COV2-Vaccination
por: Jayananda, Sriraksha
Publicado: (2021)

Is it possible to make a common reference standard for D‐dimer measurements? Communication from the ISTH SSC Subcommittee on Fibrinolysis
por: Bevan, Sally, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a9g9o6k1i5jnn2nr5jp9qscbis